Page last updated: 2024-10-25

deferoxamine and Urinary Tract Infections

deferoxamine has been researched along with Urinary Tract Infections in 1 studies

Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.

Urinary Tract Infections: Inflammatory responses of the epithelium of the URINARY TRACT to microbial invasions. They are often bacterial infections with associated BACTERIURIA and PYURIA.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lowy, FD1
Pollack, S1
Fadl-Allah, N1
Steigbigel, NH1

Other Studies

1 other study available for deferoxamine and Urinary Tract Infections

ArticleYear
Susceptibilities of bacterial and fungal urinary tract isolates to desferrioxamine.
    Antimicrobial agents and chemotherapy, 1984, Volume: 25, Issue:3

    Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Deferoxamine; Fungi; Humans; Microbial Sensi

1984